Lundbeck will supply Russia with medicine for as long as sanctions allow
As long as Lundbeck is able to supply drugs to patients in Russia under current sanctions, the pharmaceutical firm will do so, says Chief Commercial Officer Jacob Tolstrup.
by ANDREAS LØNSTRUP, translated by daniel pedersen
Despite Russia’s invasion of neighboring country Ukraine, which has resulted in extensive sanctions against the aggressor from the Western world, Danish pharmaceutical firm Lundbeck will continue its activities there.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
GN suspends all trading with Russia
For subscribers
